Institutional Manager · CIK 0001553936
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
HONG KONG, K3 · File #028-15146
Latest AUM
$30.9M
Positions
4
Top-10 Concentration
100.0%
Filings
11
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Sep 20254 pos · $30.9M
- 13F HOLDINGS REPORTQ/E Jun 20256 pos · $34.5M
- 13F HOLDINGS REPORTQ/E Mar 20255 pos · $23.6M
- 13F HOLDINGS REPORTQ/E Dec 202437 pos · $398.4M
- 13F HOLDINGS REPORTQ/E Sep 202434 pos · $356.7M
- 13F HOLDINGS REPORTQ/E Jun 202440 pos · $491.7M
- 13F HOLDINGS REPORTQ/E Mar 202441 pos · $584.9M
- 13F HOLDINGS REPORTQ/E Dec 202341 pos · $715.7M
- 13F HOLDINGS REPORTQ/E Sep 202349 pos · $925.3M
- 13F HOLDINGS REPORTQ/E Jun 202349 pos · $993.2M
- 13F HOLDINGS REPORTQ/E Mar 202327 pos · $1.00B
Top 4 Holdings — Sep 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | TAYSHA GENE THERAPIES INC (TSHA US) | TSHA | 3,700,000 | $12.1M | 39.11% |
| 2 | FORTE BIOSCIENCES INC (FBRX US) | FBRX | 786,647 | $11.8M | 38.15% |
| 3 | ALUMIS INC (ALMS US) | ALMS | 1,399,250 | $5.6M | 18.05% |
| 4 | ZENTALIS PHARMACEUTICALS INC (ZNTL US) | ZNTL | 961,486 | $1.5M | 4.69% |